Cargando…
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials. AREAS OF UNCERTAINTY: We assessed the efficacy of ivermectin treatment in reducing mortality, in secondar...
Autores principales: | Bryant, Andrew, Lawrie, Theresa A., Dowswell, Therese, Fordham, Edmund J., Mitchell, Scott, Hill, Sarah R., Tham, Tony C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal of Therapeutics
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248252/ https://www.ncbi.nlm.nih.gov/pubmed/34145166 http://dx.doi.org/10.1097/MJT.0000000000001402 |
Ejemplares similares
-
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
por: Kory, Pierre, et al.
Publicado: (2021) -
Residual Disease After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias
por: Bryant, Andrew, et al.
Publicado: (2022) -
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis
por: Bryant, Andrew, et al.
Publicado: (2022) -
Inhibition of Plasmodium Liver Infection by Ivermectin
por: Mendes, António M., et al.
Publicado: (2017) -
Roux-en-Y augmented gastric advancement: An alternative technique for concurrent esophageal and pyloric stenosis secondary to corrosive intake
por: Waseem, Talat, et al.
Publicado: (2016)